Qilu Pharmaceutical Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
0
Ending by 2030
Jan 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,916,574 | 4-(Substituted Anilino)-Quinazoline Derivatives Useful as Tyrosine Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 8,920,835 | Paliperidone Double-Layered Osmotic Pump Controlled Release Tablet and Preparation Method Thereof In force · High confidence | In force | High confidence | |
| US 10,053,477 | Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide In force · From the USPTO record | In force | From the USPTO record | |
| US 10,253,030 | Crystal form, preparation method and intermediate of dihydropyrido ring compound In force · From the USPTO record | In force | From the USPTO record | |
| US 10,738,051 | β-lactamase inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 10,662,198 | Polymorphic form of compound, preparation method and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,180,501 | Crystal form of β-lactamase inhibitor and preparation method therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 12,415,853 | Antibody Against Claudin 18A2 and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,767,650 | Crystal Form of Entrectinib and Preparation Method Therefor In force · High confidence | In force | High confidence | |
| US 12,606,578 | Crystal Form of Spirocyclic Amine Aryl Phosphorus Oxide Compound and Preparation Method Therefor In force · High confidence | In force | High confidence |
Also on record, not counted in the 12: 3 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 5 no status recorded